Effects of Rapamycin on Bone Growth in Young Rats
Author Information
Author(s): Cheryl P Sanchez, He Yu-Zhu
Primary Institution: University of Wisconsin School of Medicine & Public Health
Hypothesis
Rapamycin therapy negatively affects endochondral bone growth in young rats.
Conclusion
Rapamycin significantly decreased endochondral bone growth in young rats after 2 weeks of treatment, with no catch-up growth observed after 4 weeks.
Supporting Evidence
- Body length measurements declined by 11 percent and 19 percent after 2 and 4 weeks of Rapamycin.
- Tibial length measurements were 6 to 10 percent shorter in both Rapamycin groups.
- Histone-4 protein expression declined by 60 percent after 2 weeks of rapamycin compared to Control.
Takeaway
When young rats took rapamycin, their bones didn't grow as much, and they didn't catch up later.
Methodology
Weanling rats were given rapamycin or saline for 2 or 4 weeks, and various measurements and analyses were performed to assess bone growth and chondrocyte activity.
Potential Biases
Potential bias in the interpretation of histological and biochemical data due to the semi-quantitative nature of the methods used.
Limitations
The study's findings may not directly translate to human pediatric patients due to differences in species and the dosage used.
Participant Demographics
26 male Sprague-Dawley rats, 3 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website